These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2578278)

  • 1. Hydroxyethyl starch in CABG.
    Diehl JT
    Ann Thorac Surg; 1985 Jan; 39(1):97-8. PubMed ID: 2578278
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.
    Winkelmayer WC; Glynn RJ; Levin R; Avorn J
    Kidney Int; 2003 Sep; 64(3):1046-9. PubMed ID: 12911555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
    Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?
    Collins JA; Litwin MS; Lutz H; Klose R; Ring J; Thorén L; Tschirren B; Lundsgaard-Hansen P
    Vox Sang; 1979; 36(1):39-49. PubMed ID: 85370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch.
    Belcher P; Lennox SC
    Ann Thorac Surg; 1984 May; 37(5):365-70. PubMed ID: 6201145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass.
    Lumb PD
    Ann Surg; 1987 Aug; 206(2):210-3. PubMed ID: 2440391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].
    Thompson WL
    Infusionsther Klin Ernahr; 1979 Aug; 6(4):262-3. PubMed ID: 90652
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery.
    Hicks GL; Jensen LA; Norsen LH; Quinn JR; Stewart SS; DeWeese JA
    Ann Thorac Surg; 1985 May; 39(5):422-5. PubMed ID: 2581521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?
    Belcher PR; Muriithi EW
    Eur J Cardiothorac Surg; 2001 Nov; 20(5):1078-9. PubMed ID: 11675220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hemorrhagic shock with hydroxyethyl starch, total-dose imferon infusion, and mass spectrophotometry.
    Sassano JJ; Sladen A; Franklin RH; Guntupalli KK
    Crit Care Med; 1982 Jul; 10(7):484-5. PubMed ID: 6177471
    [No Abstract]   [Full Text] [Related]  

  • 16. New dosage regimens for HES during intensive leukapheresis.
    Mishler JM
    Transfusion; 1978; 18(1):126-7. PubMed ID: 75600
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma expanders and bleeding.
    Abramson N
    Ann Intern Med; 1988 Feb; 108(2):307. PubMed ID: 2449107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 19. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease.
    Ernst E; Matrai A; Kollar L
    Angiology; 1989 May; 40(5):479-83. PubMed ID: 2468300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.